In partnership with

Today’s edition is sponsored by TLDR. Their support keeps these briefings free and focused on what actually matters.

Deadlines, Decoded launches today. The first issue goes out at 10 AM, and since it’s a separate list, this is your last chance to sign up and get it.

Alberta’s securities regulator turned down Curaleaf’s bid to stop Aurora from selling shares while its hostile offer is open. Virginia Gov. Abigail Spanberger said the timing of Sen. Louise Lucas’s indictment erodes trust in the Justice Department. Massachusetts regulators proposed letting out-of-state patients register for medical cannabis with a Massachusetts clinician’s certification. Michigan’s Republican ticket wants a year off the 24 percent wholesale tax, Safe Harbor Financial signed a term sheet to combine with a media company, and Georgia opened a dispensing window as its registry passed 56,000 patients.

🥊 One ruling, no surrender
🏖️ Vacation pharmacy rules
🍗 Why a year?
🏦 What’s it up to?

❝

A chicken for every pot.

Republican Business Men, Inc., campaign advertisement (1928)
Deadlines, Decoded from Policy, Decoded launches today. First issue at 10 AM. Sign up free.

The Alberta Securities Commission on Monday dismissed Curaleaf’s application to stop Aurora Cannabis from selling shares through its at-the-market program while Curaleaf’s hostile bid is open. Aurora, which announced the ruling, says it last used the program August 18th and hasn’t touched it during the bid. The offer stands at US$1.00 plus 0.4013 Curaleaf shares through December 4th, and Aurora’s board is still telling shareholders not to tender. Curaleaf wants a European supply chain. Aurora brings more than 50 tons a year of EU-GMP cultivation and manufacturing capacity, including Pedanios in Germany. Curaleaf’s international business brought in $172.5 million last year, up 63 percent, while its U.S. prices fell for a third straight year. Is this a sign of the future for companies in this space? Cannabis has certainly never done things normally, and receiverships have already become one of its quirks. Will we see a renaissance of corporate spats, too? I’m curious to see how this one plays out. (StratCann; Business of Cannabis; Curaleaf)

Your take: Is Curaleaf’s run at Aurora the start of more hostile deals in cannabis, or a one-off? Hit reply. It comes straight to me, and I read every one.

🏛️ Virginia Gov. Abigail Spanberger said Thursday that Sen. L. Louise Lucas is presumed innocent, and that the timing of the federal indictment “further erodes the trust” Americans should have in the Justice Department. Spanberger has had a rocky early tenure with cannabis. The Senate rejected her April amendments to the retail bill 21-18, she vetoed it in May, and lawmakers wrote retail sales into the budget instead, starting July 1st, 2027. This indictment is radioactive for her politically, since it’s cannabis-related, the source of her early clash with the legislature, and Trump-adjacent, which is pure politics. (WJLA; WTKR; The Washington Times)

The Cannabis Control Commission took up a proposal at its October 22nd meeting that would let nonresident adults register as medical patients if a Massachusetts clinician certifies a qualifying condition. A card from another state wouldn’t be enough on its own, and patients under 18 would face added criteria. An initial vote is planned for December 10th, with public comment reportedly running January 1st through February 2nd. I’ve always been in favor of this. If I’m on vacation, I can walk into a CVS or Walgreens and have my prescription filled, or have my provider call it in to a local pharmacy using, of all things, their DEA registration. Massachusetts is enough of a tourist state that the option is relevant, and plenty of our own patients travel to Maine for their medicine anyway. This is logical. It should help operators, buoy the medical market, and hopefully get patients more attention at retail on price and variety. As a regulator, I’d say any discount or deal offered to new out-of-state patients has to be available to Massachusetts patients, too. (CommonWealth Beacon; State House News Service)

🎬 The five members of Broken Lizard, the comedy troupe behind Super Troopers, released a video Monday urging Massachusetts voters to reject Question 8, paid for by the Committee for Responsible Cannabis Policy. “Littering and... smoking the reefer.” I didn’t expect my work and my childhood to end up in the same video. As if I needed another reason to vote no on 8. The case for voting no is at StoptheRepealMA.com. (Marijuana Moment; Talking Joints Memo)

Rep. Jay DeBoyer, John James’s running mate, says he’ll propose suspending Michigan’s 24 percent wholesale cannabis tax for 12 months. The tax took effect January 1st, on top of the 10 percent excise and 6 percent sales tax. Citing the State Budget Office, Cannabis Business Times reports $73.4 million collected in the first six months against a $420.7 million annual projection. No bill has been filed, and a separate repeal, S.B. 810, has sat in the Senate Government Operations Committee since February. It is definitely campaign season. A chicken in every pot and a car in every garage. But why a year? Why not two? Why not just repeal it? A promise like this only matters if there’s accountability for keeping it, and there often isn’t. (Cannabis Business Times)

🍑 Georgia opened a five-day window Monday for its six licensed producers to apply for more dispensing licenses, after the registry passed the 55,000-patient mark that raises the cap to nine dispensaries per producer. The Marijuana Herald counts 56,650 active patients as of September 23rd, up from 36,703 at the end of June. Georgia’s market is making moves. It’s likely retaining more of its own residents and will see interesting growth. Politically, the state is squarely focused on medical, but it’s an interesting market to watch. The next window runs January 25th through 29th. (The Marijuana Herald)

Five plans to discontinue its 2 milligram and 10 milligram THC seltzers on December 11th, when the federal limit of 0.4 milligrams of total THC per container reaches hemp products generally. Cannabinoids the plant can’t produce on its own lose hemp status sooner, on November 12th. Whitney Economics estimates put $28.3 billion in hemp-derived THC revenue and 225,000 jobs at stake. Of course brands are making product decisions. They’ve had a year to prepare since Congress rewrote the definition last November, and got only a month-long reprieve in September. They should have marked their calendars 11 months ago. At the same time, they’ve been juggling advocacy and awareness over that same stretch, and each made its own call about what was best for its business and how its time was best spent. That juggling is the daily work of an operator in a regulated industry subject to the government. (VICE; Beverage Information Group)

🏦 Safe Harbor Financial signed a nonbinding term sheet Monday to combine with Opifex Media, leaving Opifex holders with about 85 percent of the company and Safe Harbor’s stakeholders about 15 percent before new financing. Opifex chair Greg Newman would chair the combined company, and Opifex would be valued at no less than $50 million, subject to an independent valuation. The term sheet comes four weeks after a 1-for-12 reverse split and six days after Nasdaq gave the company until April 19th to get its share price back to $1. Safe Harbor says its cannabis banking services would continue. It has made some interesting moves over the last year, and a cannabis banking compliance company folding into a media holding company leaves me wondering what it’s up to. (Cannabis Business Times; SEC Form 8-K)

Social equity applicants changing interest holders have until November 6th, moved from October 30th. The Cannabis Control Commission’s adult-use retail portal closes at 4 p.m. Eastern on November 23rd, with every document due, final local zoning approvals included. Majority owners holding more than 50 percent need NCIC background checks by December 4th. The round covers up to 24 licenses across six regions, with slots reserved for social equity applicants and worker cooperatives. We’re entering the holiday season, and between vacations and short weeks, dates like these start sneaking up on people. Deadlines, Decoded keeps them in one place. (Vicente LLP; Rhode Island Cannabis Control Commission)

🗺️ Around the map: Minnesota’s Office of Cannabis Management has $10.9 million in CanRenew grants available for communities harmed by past enforcement, with applications due December 15th. The National Drug Early Warning System reported a statistically significant national decline in EMS encounters suspected of involving cannabis, across 169,468 encounters from January 2024 through mid-2026. Maryland labs must report per-serving THC in Metrc for edibles, beverages and sublingual pouches starting November 5th. In New Hampshire, Gov. Kelly Ayotte and Democrat Cinde Warmington split on adult-use legalization at a Manchester debate. The Council of the European Union agreed a negotiating position bringing every part of the hemp plant under its farm market rules, with talks with Parliament still ahead. (KIMT; The Marijuana Herald; The Dartmouth; Ganjapreneur)

The daily newsletter for finding AI tools worth trying

New AI tools launch every day. A few will change how you work. The rest will be forgotten by next month.

TLDR AI is the free newsletter that tells you which is which. Every morning, Anthropic and ex-Google engineers pick the new tools, updates, and open source releases worth trying, with a quick note on what each one does and who it's for.

You find the good ones early, without testing all of them.

One email, 5 minutes a day, read by 1.1M+ people. Get tomorrow's picks.

Deadlines, Decoded launches today. First issue at 10 AM. Sign up free.

What takes effect next, each date linked to the document that set it.

TomorrowDistrict of Columbia: Emergency act letting conditional medical cannabis licensees convert with a zoning certificate expires (A26-0391) (October 28th)
TomorrowIdaho: Comments close on the Department of Agriculture's hemp fee rule adding retailer license fees (IDAPA 02.01.07) (October 28th)
2 daysTexas: Public hearing on the Alcoholic Beverage Commission's rule on consumable hemp use at off-premise alcohol retailers (16 TAC 35.7); comments close November 9th (October 29th)
2 daysFederal: Briefs on the GAO report due in the DEA rescheduling hearing (October 29th)
3 daysGeorgia: Regular open application period for dispensing licenses closes (October 30th)
3 daysOregon: Comments close on the Liquor and Cannabis Commission's hemp item registration resubmission rule (OAR 845-026-6100) (October 30th)
5 daysOklahoma: Medical marijuana packaging restrictions, THC labeling and edible potency cap take effect (HB 4454) (November 1st)
5 daysOklahoma: Tetrahydrocannabinols move to Schedule I, including THC derived from industrial hemp (SB 1257) (November 1st)
5 daysIllinois: Cannabis product labels must show total THC and full cannabinoid disclosure (November 1st)
5 daysColorado: 2026 annual marijuana rules take effect (1 CCR 212-3) (November 1st)
5 daysColorado: New Metrc inventory tracking contract begins with lower plant tag fees (MED Bulletin 26-08) (November 1st)
5 daysVirginia: Selling products above the THC limits becomes a prohibited practice (SB 543) (November 1st)
5 daysNorth Dakota: Medical marijuana compassion center certification fees rise (November 1st)
6 daysUtah: Comments close on the hemp retailer permit renewal date change (R66-34) (November 2nd)
7 daysMassachusetts: Statewide vote on Question 8 to prohibit the retail sale of adult use marijuana (November 3rd)
9 daysNew York: Cannabis nursery license application period opens (closes at 50 applications) (November 5th)
9 daysMaryland: Per-serving THC reporting becomes required in Metrc for edibles, beverages and sublingual pouches (Bulletin 131) (November 5th)
9 daysFederal: Replies on the GAO report due in the DEA rescheduling hearing; the stay lifts when briefing closes (November 5th)
10 daysRhode Island: Social Equity Applicant Interest Holder Change Requests due (4 p.m. ET; moved from October 30) (November 6th)
14 daysWashington: Comments close and public hearing on the Department of Health's medical cannabis product compliance rules (WAC 246-70) (November 10th)
43 daysFederal: Comments close on the FDA rule making GRAS notification mandatory (December 9th)
45 daysFederal: Section 781 hemp restrictions apply in full as the enacted delay ends (December 11th)
65 daysFederal: USDA enforcement discretion on DEA-registered hemp testing laboratories ends (December 31st)

That's what lands in the next few weeks. The full ledger runs to every open date in every state, filterable by jurisdiction and by type, reviewed each morning. See the whole ledger

SHARE THE BRIEFING

Policy, Decoded grows best when it's shared deliberately. Refer three people and you get 30 minutes with me, one on one, on whatever policy issue is actually in front of you. One referral earns a sticker pack, five earns How to Be Heard, our guide to making public comment that regulators actually read, and ten earns the Field Kit.

Recommended for you

View all
caret-right